Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2003Arthritis & Rheumatism

Clinical responses to tumor necrosis factor α antagonists do not show a bimodal distribution: Data from the Stockholm Tumor Necrosis Factor α Followup Registry

View Full Paper
Ask AI
Bookmark
Share

Authors

Ronald van VollenhovenRonald van VollenhovenRoche (Switzerland)Lars KlareskogLars KlareskogUppsala University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vollenhoven et al. (2003) studied this question.

synapsesocial.com/papers/6a2190ec96850e9b858b9501https://doi.org/10.1002/art.11027
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteria1996 · 1,581 citations
  2. 2Measurement of patient outcome in arthritis1980 · 4,420 citations
  3. 3Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis1995 · 6,288 citations
  4. 4American college of rheumatology preliminary definition of improvement in rheumatoid arthritis1995 · 2,851 citations
  5. 5Should imporvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?1998 · 192 citations